Background— Inflammation is a feature of pulmonary arterial hypertension (PAH), and
increased circulating levels of cytokines are reported in patients with PAH. However, to date, no …

Objective— MicroRNAs (miRNAs) are small noncoding RNAs that have the capacity to control
protein production through binding “seed” sequences within a target mRNA. Each miRNA …

… Other limitations of the study include the disparities between the two groups at baseline and
the fact that some subjects were recruited too soon after surgery. It is also unclear whether …

Rationale: Severe pulmonary arterial hypertension (PAH) is characterized by the formation
of plexiform lesions and concentric intimal fibrosis in small pulmonary arteries. The origin of …

Rationale: Mutations in bone morphogenetic protein receptor type II (BMPR-II) underlie most
cases of heritable pulmonary arterial hypertension (PAH). However, disease penetrance is …

Background— Beyond their role as innate immune effectors, natural killer (NK) cells are
emerging as important regulators of angiogenesis and vascular remodeling. Pulmonary arterial …

Background Anaemia is common in left heart failure and is associated with a poorer
outcome. Many patients with pulmonary arterial hypertension (PAH) are anaemic or iron-deficient. …

This study analyzed the relationship between pulmonary vascular resistance (PVR) and
pulmonary arterial compliance (C a ) in patients with idiopathic pulmonary arterial hypertension (…

The past decade has seen increased application of 18-flurodeoxyglucose positron emission
tomography ( 18 FDG-PET) imaging to help diagnose and monitor disease, particularly in …

Rationale: Schistosomiasis is the most common worldwide cause of pulmonary arterial
hypertension. The anti-schistosome drug praziquantel has been shown to reverse the liver …